3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
5
Phase 2
2
Phase 1/2
2
Phase NA
1
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Breast Neoplasms
433
Neoplasms
371
Prostatic Neoplasms
206
Lung Neoplasms
195
Colorectal Neoplasms
151
Motor Activity
94
Uterine Cervical Neoplasms
83
Pancreatic Neoplasms
78
Carcinoma, Non-Small-Cell Lung
75
Head and Neck Neoplasms
74
Brain Neoplasms
69
Ovarian Neoplasms
65
Carcinoma, Hepatocellular
53
Colonic Neoplasms
51
Rectal Neoplasms
50
Neoplasm Metastasis
50
Anxiety Disorders
46
Precursor Cell Lymphoblastic Leukemia-Lymphoma
45
Glioblastoma
43
Hematologic Neoplasms
42
Depression
41
Melanoma
37
Glioma
37
Disease
37
Stomach Neoplasms
35
Sarcoma
35
Multiple Myeloma
34
Pain
32
Carcinoma, Renal Cell
32
Lymphoma
31
Interventions
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Diabetes Mellitus, Insulin-Dependent, 12
×
90 days
×
Clear all
NCT04253080
2026-05-20
ENZYMELA
Assistance Publique - Hôpitaux de Paris
Phase NA
Completed
127 enrolled